Market Highlights
The increasing awareness about contraceptive methods,
increasing number of unintended pregnancies, and government support and
initiatives for the prevention of unwanted abortions & pregnancies are set
to drive the demand for Intrauterine
Contraceptive Devices Market Report during the forecast period.
Intrauterine Contraceptive Devices Market is expected to
cross USD 5.62 Billion by 2032 at a CAGR of 10.9% during the forecasted period
2023-2032.
Contraceptive devices are used to prevent unwanted pregnancy
by restricting the natural ovulation
cycle or making changes in the egg fertilization process. Intrauterine
contraceptive devices are placed inside the uterus to avoid unintended
pregnancy. These devices contain a string which guarantees the precise
placement of the device inside the uterus and provide aid in removal. lifespan
of these devices varies as per the brands, and it can last up to 3,5 and 10
years. Plastic and metal are used in manufacturing of intrauterine
contraceptive devices (IUCDs). It is available in several shapes, such as coil,
loop, triangle, and T-shaped.
Key Players
Some of the key Intrauterine Contraceptive Devices Market
Players are
·
Bayer AG,
·
The Cooper Companies, Inc.,
·
Pfizer Inc.,
·
HLL Lifecare Limited,
·
OCON Healthcare,
·
SMB Corporation,
·
Egemen International,
·
EUROGINE,
·
S.L.,
·
Meril Life Sciences Pvt. Ltd.,
·
Mona Lisa N.V.,
·
Prosan International B.V.,
·
Pregna International Limited
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Asia-Pacific is anticipated to hold the largest market
share. The intrauterine contraceptive devices (IUCDs) market in Asia-Pacific
has been segmented into Japan, China, India, South Korea, Australia, and the
rest of Asia-Pacific. Due to the presence of a large patient pool, developing
the healthcare sector, and raising awareness about intrauterine contraceptive
devices the region.
The Americas is anticipated to be the fastest-growing market
owing to the rising number of unintended pregnancies, well-established
healthcare sector, and increasing healthcare expenditure. The intrauterine
contraceptive devices (IUCDs) market in the Americas has further been branched
into North America and Latin America, with the North American market being
divided into the US and Canada.
The European intrauterine contraceptive devices (IUCDs)
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The intrauterine contraceptive devices
(IUCDs) market in the Middle East & Africa has been divided into the Middle
East and Africa.
Segmentation
The global intrauterine contraceptive devices (IUCDs) market overview has been segmented based on type and end user.
· The market, based on type, has been divided into a hormonal intrauterine device and copper intrauterine device. Copper intrauterine devices are likely to hold the maximum market share in the global intrauterine contraceptive devices (IUCDs) market.
· The end user segment of the market consists of hospitals, gynecology clinics, community health care centers, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
No comments:
Post a Comment